Copyright Reports & Markets. All rights reserved.

Global Monoclonal Mouse Antibody Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Monoclonal Mouse Antibody Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 IgM
      • 1.4.3 IgG
      • 1.4.4 IgA
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Monoclonal Mouse Antibody Market Share by Application (2014-2025)
      • 1.5.2 Therapeutic
      • 1.5.3 Research
      • 1.5.4 Diagnostic
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Monoclonal Mouse Antibody Market Size
    • 2.2 Monoclonal Mouse Antibody Growth Trends by Regions
      • 2.2.1 Monoclonal Mouse Antibody Market Size by Regions (2014-2025)
      • 2.2.2 Monoclonal Mouse Antibody Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Monoclonal Mouse Antibody Market Size by Manufacturers
      • 3.1.1 Global Monoclonal Mouse Antibody Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Monoclonal Mouse Antibody Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Monoclonal Mouse Antibody Market Concentration Ratio (CR5 and HHI)
    • 3.2 Monoclonal Mouse Antibody Key Players Head office and Area Served
    • 3.3 Key Players Monoclonal Mouse Antibody Product/Solution/Service
    • 3.4 Date of Enter into Monoclonal Mouse Antibody Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Monoclonal Mouse Antibody Market Size by Type (2014-2019)
    • 4.2 Global Monoclonal Mouse Antibody Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Monoclonal Mouse Antibody Market Size (2014-2019)
    • 5.2 Monoclonal Mouse Antibody Key Players in United States
    • 5.3 United States Monoclonal Mouse Antibody Market Size by Type
    • 5.4 United States Monoclonal Mouse Antibody Market Size by Application

    6 Europe

    • 6.1 Europe Monoclonal Mouse Antibody Market Size (2014-2019)
    • 6.2 Monoclonal Mouse Antibody Key Players in Europe
    • 6.3 Europe Monoclonal Mouse Antibody Market Size by Type
    • 6.4 Europe Monoclonal Mouse Antibody Market Size by Application

    7 China

    • 7.1 China Monoclonal Mouse Antibody Market Size (2014-2019)
    • 7.2 Monoclonal Mouse Antibody Key Players in China
    • 7.3 China Monoclonal Mouse Antibody Market Size by Type
    • 7.4 China Monoclonal Mouse Antibody Market Size by Application

    8 Japan

    • 8.1 Japan Monoclonal Mouse Antibody Market Size (2014-2019)
    • 8.2 Monoclonal Mouse Antibody Key Players in Japan
    • 8.3 Japan Monoclonal Mouse Antibody Market Size by Type
    • 8.4 Japan Monoclonal Mouse Antibody Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Monoclonal Mouse Antibody Market Size (2014-2019)
    • 9.2 Monoclonal Mouse Antibody Key Players in Southeast Asia
    • 9.3 Southeast Asia Monoclonal Mouse Antibody Market Size by Type
    • 9.4 Southeast Asia Monoclonal Mouse Antibody Market Size by Application

    10 India

    • 10.1 India Monoclonal Mouse Antibody Market Size (2014-2019)
    • 10.2 Monoclonal Mouse Antibody Key Players in India
    • 10.3 India Monoclonal Mouse Antibody Market Size by Type
    • 10.4 India Monoclonal Mouse Antibody Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Monoclonal Mouse Antibody Market Size (2014-2019)
    • 11.2 Monoclonal Mouse Antibody Key Players in Central & South America
    • 11.3 Central & South America Monoclonal Mouse Antibody Market Size by Type
    • 11.4 Central & South America Monoclonal Mouse Antibody Market Size by Application

    12 International Players Profiles

    • 12.1 Roche
      • 12.1.1 Roche Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Monoclonal Mouse Antibody Introduction
      • 12.1.4 Roche Revenue in Monoclonal Mouse Antibody Business (2014-2019)
      • 12.1.5 Roche Recent Development
    • 12.2 Johnson & Johnson
      • 12.2.1 Johnson & Johnson Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Monoclonal Mouse Antibody Introduction
      • 12.2.4 Johnson & Johnson Revenue in Monoclonal Mouse Antibody Business (2014-2019)
      • 12.2.5 Johnson & Johnson Recent Development
    • 12.3 Merck
      • 12.3.1 Merck Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Monoclonal Mouse Antibody Introduction
      • 12.3.4 Merck Revenue in Monoclonal Mouse Antibody Business (2014-2019)
      • 12.3.5 Merck Recent Development
    • 12.4 Novartis
      • 12.4.1 Novartis Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Monoclonal Mouse Antibody Introduction
      • 12.4.4 Novartis Revenue in Monoclonal Mouse Antibody Business (2014-2019)
      • 12.4.5 Novartis Recent Development
    • 12.5 AbbVie
      • 12.5.1 AbbVie Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Monoclonal Mouse Antibody Introduction
      • 12.5.4 AbbVie Revenue in Monoclonal Mouse Antibody Business (2014-2019)
      • 12.5.5 AbbVie Recent Development
    • 12.6 Amgen
      • 12.6.1 Amgen Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Monoclonal Mouse Antibody Introduction
      • 12.6.4 Amgen Revenue in Monoclonal Mouse Antibody Business (2014-2019)
      • 12.6.5 Amgen Recent Development
    • 12.7 Pfizer
      • 12.7.1 Pfizer Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Monoclonal Mouse Antibody Introduction
      • 12.7.4 Pfizer Revenue in Monoclonal Mouse Antibody Business (2014-2019)
      • 12.7.5 Pfizer Recent Development
    • 12.8 Bayer
      • 12.8.1 Bayer Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Monoclonal Mouse Antibody Introduction
      • 12.8.4 Bayer Revenue in Monoclonal Mouse Antibody Business (2014-2019)
      • 12.8.5 Bayer Recent Development
    • 12.9 Lilly
      • 12.9.1 Lilly Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Monoclonal Mouse Antibody Introduction
      • 12.9.4 Lilly Revenue in Monoclonal Mouse Antibody Business (2014-2019)
      • 12.9.5 Lilly Recent Development
    • 12.10 Bristol-Myers Squibb
      • 12.10.1 Bristol-Myers Squibb Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Monoclonal Mouse Antibody Introduction
      • 12.10.4 Bristol-Myers Squibb Revenue in Monoclonal Mouse Antibody Business (2014-2019)
      • 12.10.5 Bristol-Myers Squibb Recent Development
    • 12.11 GlaxoSmithKline
    • 12.12 Biogen
    • 12.13 AstraZeneca
    • 12.14 Sanofi
    • 12.15 Alexion Pharmaceuticals
    • 12.16 Seattle Genetics

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
      For antibody discovery, mice are one of the most important sources. They produce similar antibody isotypes with human, including IgA, IgD, IgE, IgG and IgM. Compared with the subclasses of human antibody isotypes, mice contain only one IgA class and the IgG subclasses are known as IgG1, IgG2a, IgG2b and IgG3. In addition, laboratory mice can induce a good immune response to a great range of antigens, even those highly homological human proteins. Moreover, some treatments that unacceptable for humans can also be aboveboard applied for mice with results which are analogous to that from humans. Therefore, the development of mouse monoclonal antibodies is a common choice for a variety of therapeutics and pathology researches. Up to now, the rapid development of therapeutic antibody in the pharmaceutical industry has enabled the mice to play an important role in both monoclonal antibodies discovery and the pre-clinical assessment.
      The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Seattle Genetics and so on.
      The leading companies own the advantages on better performance, more abundant product’s types, better technical and impeccable after-sales service. Consequently, they take the majority of the market share of high-end market. Looking to the future years, the slow downward price trend in recent years will maintain. As competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.
      In 2018, the global Monoclonal Mouse Antibody market size was 7330 million US$ and it is expected to reach 11200 million US$ by the end of 2025, with a CAGR of 5.4% during 2019-2025.

      This report focuses on the global Monoclonal Mouse Antibody status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Monoclonal Mouse Antibody development in United States, Europe and China.

      The key players covered in this study
      Roche
      Johnson & Johnson
      Merck
      Novartis
      AbbVie
      Amgen
      Pfizer
      Bayer
      Lilly
      Bristol-Myers Squibb
      GlaxoSmithKline
      Biogen
      AstraZeneca
      Sanofi
      Alexion Pharmaceuticals
      Seattle Genetics

      Market segment by Type, the product can be split into
      IgM
      IgG
      IgA
      Other

      Market segment by Application, split into
      Therapeutic
      Research
      Diagnostic

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Monoclonal Mouse Antibody status, future forecast, growth opportunity, key market and key players.
      To present the Monoclonal Mouse Antibody development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Monoclonal Mouse Antibody are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now